COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 514: Articles 5131-5140  | Next

Wastewater genomic surveillance captures early detection of Omicron in Utah
Gupta, P., Liao, S., Ezekiel, M., Novak, N., Rossi, A., LaCross, N., Oakeson, K., Rohrwasser, A.
10.1101/2022.11.24.22282643 — Posted: 2022-11-29
Mortality due to SARS COV-2 And its Associated Factors in East Shewa Zone Treatment Centers, Ethiopia, 2022: A retrospective cross-sectional study
Ali, J. H., Getinet, T., Botore, A., Bekele, M., Bekele, B., Jalata, F., Abebe, W., Sisay, M., Getahun, A., Ligdi, T.
10.1101/2022.11.28.22282830 — Posted: 2022-11-29
Rethinking Transfer Learning for Medical Image Classification
Peng, L., Liang, H., Luo, G., Li, T., Sun, J.
10.1101/2022.11.26.22282782 — Posted: 2022-11-29
The Detection of COVID-19 in Chest X-Rays Using Ensemble CNN Techniques
Kuzinkovas, D., Clement, S.
10.1101/2022.11.29.22282856 — Posted: 2022-11-29
The influence of COVID-19 risk perception and vaccination status on the number of social contacts across Europe: insights from the CoMix study
Wambua, J., Loedy, N., Jarvis, C. I., Wong, K. L., Faes, C., Grah, R., Prasse, B., Sandmann, F., Niehus, R., Johnson, H., Edmunds, W. J., Beutels, P., Hens, N., Coletti, P.
10.1101/2022.11.25.22282676 — Posted: 2022-11-29
Exploring a targeted approach for public health capacity restrictions during COVID-19 using a new computational model
Micuda, A., Anderson, M. R., Babayan, I., Bolger, E., Cantin, L., Groth, G., Pressman-Cyna, R., Reed, C. Z., Rowe, N. J., Shafiee, M., Tam, B., Vidal, M. C., Ye, T., Martin, R. D.
10.1101/2022.11.28.22282818 — Posted: 2022-11-29
Performance of antigen lateral flow devices in the United Kingdom during the Alpha, Delta, and Omicron waves of the SARS-CoV-2 pandemic
Eyre, D. W., Futschik, M., Tunkel, S., Wei, J., Cole-Hamilton, J., Saquib, R., Germanacos, N., Dodgson, A., Klapper, P. E., Sudhanva, M., Kenny, C., Marks, P., Blandford, E., Hopkins, S., Peto, T., Fowler, T.
10.1101/2022.11.29.22282899 — Posted: 2022-11-29
SARS-CoV-2 Vaccine Booster Elicits Robust Prolonged Maternal Antibody Responses and Passive Transfer Via The Placenta And Breastmilk
Marshall, N. E., Blanton, M. B., Doratt, B. M., Malherbe, D. C., Rincon, M., True, H., McDonald, T., Beauregard, C., Adatorwovor, R., Messaoudi, I.
10.1101/2022.11.29.518385 — Posted: 2022-11-29
A systematic review and meta-analysis comparing the diagnostic accuracy tests of COVID-19
Vilca Alosilla, J. J., Candia Puma, M. A., Coronel Monje, K., Goyzueta Mamani, L. D., Sobreira Galdino, A., Machado de Avila, R. A., Cordeiro Giunchetti, R., Ferraz Coelho, E. A., Chavez Fumagalli, M. A.
10.1101/2022.11.29.22282895 — Posted: 2022-11-29
Brewpitopes: a pipeline to refine B-cell epitope predictions during public health emergencies
Farriol-Duran, R., Lopez-Aladid, R., Porta-Pardo, E., Torres, A., Fernandez-Barat, L.
10.1101/2022.11.28.518301 — Posted: 2022-11-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).